Norges Bank
DNA icon

Norges Bank’s Ginkgo Bioworks DNA Stock Holding History

Norges Bank’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-390,696
Closed -$5.22M – 1871
2024
Q2 		$5.22M Buy
390,696
+3,671
+0.9% +$110K ﹤0.01% 1551
2024
Q1 		$18M Buy
387,025
+17,698
+5% +$916K ﹤0.01% 1297
2023
Q4 		$25M Buy
369,327
+29,052
+9% +$1.78M ﹤0.01% 1206
2023
Q3 		$24.6M Buy
340,275
+101,350
+42% +$8.1M 0.01% 1146
2023
Q2 		$17.8M Buy
238,925
+80,060
+50% +$4.74M ﹤0.01% 1305
2023
Q1 		$8.45M Sell
158,865
-37,976
-19% -$2.41M ﹤0.01% 1636
2022
Q4 		$13.3M Buy
196,841
+192,033
+3,994% +$17.7M ﹤0.01% 1455
2022
Q3 		$600K Buy
+4,808
New +$573K ﹤0.01% 2043

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Norges Bank's DNA Position: Q3 2024 in Review

Norges Bank sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 390,696 shares — an estimated $5.22M sold.

Norges Bank first reported a position in DNA in Q3 2022 and held it in 8 quarters. The position peaked at $25M in Q4 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Norges Bank reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Norges Bank sold 390,696 Ginkgo Bioworks shares in Q3 2024, an estimated $5.22M.
  • Norges Bank first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 8 quarters.
  • Norges Bank's Ginkgo Bioworks position peaked at $25M in Q4 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.